Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH)
A. Boucly (Le Kremlin Bicêtre, France), L. Savale (Le Kremlin Bicêtre, France), J. Weatherald (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France), M. Jevnikar (Le Kremlin Bicêtre, France), X. Jaïs (Le Kremlin Bicêtre, France), G. Simonneau (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France)
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boucly (Le Kremlin Bicêtre, France), L. Savale (Le Kremlin Bicêtre, France), J. Weatherald (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France), M. Jevnikar (Le Kremlin Bicêtre, France), X. Jaïs (Le Kremlin Bicêtre, France), G. Simonneau (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France). Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH). 271
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: